Market Overview

Regulus Therapeutics (NASDAQ: RGLS)

0.99 +0.02 (2.34%)

Earnings

QuarterPriorEstimateActualSurprise
Q1 2020
After-Hours
EPS:
REV:
-0.31
6.778M



Q4 2019
Pre-Market
EPS:
REV:
-0.98
18K



Q3 2019
After-Hours
EPS:
REV:
-1.18
18K



Q2 2019
After-Hours
EPS:
REV:
-0.13
18K



Q1 2019
After-Hours
EPS:
REV:
-0.15
18K
-1.15
10K
-0.31
6.778M
73.04%
67680%
Q4 2018
Pre-Market
EPS:
REV:
-0.14
18K
-0.92
3.51M
-0.98
18K
6.52%
-99.49%
Q3 2018
After-Hours
EPS:
REV:
-0.18
18K
-1.25
10K
-1.18
18K
-5.6%
80%
Q2 2018
After-Hours
EPS:
REV:
-0.41
18K
-0.16
10K
-0.13
18K
-18.75%
80%
Q1 2018
After-Hours
EPS:
REV:
-0.38
18K
-0.14
-0.15
18K
7.14%
Q4 2017
After-Hours
EPS:
REV:
-0.38
18K
-0.16
740K
-0.14
18K
-12.5%
-97.57%

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!